Skip to main content

Table 1 General condition of 146 patients

From: Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha

 

total (n = 146)

male (n = 58)

female (n = 88)

p value

Age (year)

37.09 ± 8.51

39.41 ± 8.65

35.56 ± 8.11

0.007

Median course of treatment (weeks)

36

48

36

0.004

range

12–96

   

Baseline HBsAg level (logIU/ml)

2.87 ± 1.13

2.67 ± 1.12

3 ± 1.12

0.084

HBeAg positive (%)

62 (42.5%)

19 (32.8%)

43 (48.9%)

0.054

Baseline ALT (U/L)

20 (14, 37)

28.5 (17, 42.75)

18 (13, 30.5)

0.009

Baseline thyroid autoantibody positive

29

12

17

 
  1. ALT aspartate aminotransferase, HBsAg hepatitis B surface antigen